Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
Journal of Surgical Oncology
|
October 13, 2018
CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules
Wei Li, Shujun Xia, Anna Aronova, et al.
Nature Biomedical Engineering
|
August 7, 2023
Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer
Siyoung Choi, Matthew A Whitman, Adrian A Shimpi, et al.
JCI Insight
|
July 12, 2019
Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts
Franco B Mueller, Hua Yang, Michelle Lubetzky, et al.
Cell Reports
|
January 23, 2020
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer
Shira Yomtoubian, Sharrell B Lee, Akanksha Verma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2016
Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib
Jennifer E Amengual, Sathyen A Prabhu, Maximilian Lombardo, et al.
Endocrine-Related Cancer
|
January 29, 2019
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors
Brendan M Finnerty, Maureen D Moore, Akanksha Verma, et al.
Carcinogenesis
|
May 9, 2019
Supplemental estrogen and caloric restriction reduce obesity-induced periprostatic white adipose inflammation in mice
Priya Bhardwaj, Takahiro Ikeda, Xi Kathy Zhou, et al.
Molecular Cancer
|
May 11, 2019
Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression
Soyoung Choi, Dunrui Wang, Xiang Chen, et al.
Leukemia
|
March 4, 2020
The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK<sup>-</sup> anaplastic large cell lymphoma by regulating the DNA helicase HELLS
Valentina Fragliasso, Akanksha Verma, Gloria Manzotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2019
Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas
Jennifer K Lue, Sathyen A Prabhu, Yuxuan Liu, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
Journal of Surgical Oncology
|
October 13, 2018
CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules
Wei Li, Shujun Xia, Anna Aronova, et al.
Nature Biomedical Engineering
|
August 7, 2023
Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer
Siyoung Choi, Matthew A Whitman, Adrian A Shimpi, et al.
JCI Insight
|
July 12, 2019
Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts
Franco B Mueller, Hua Yang, Michelle Lubetzky, et al.
Cell Reports
|
January 23, 2020
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer
Shira Yomtoubian, Sharrell B Lee, Akanksha Verma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2016
Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib
Jennifer E Amengual, Sathyen A Prabhu, Maximilian Lombardo, et al.
Endocrine-Related Cancer
|
January 29, 2019
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors
Brendan M Finnerty, Maureen D Moore, Akanksha Verma, et al.
Carcinogenesis
|
May 9, 2019
Supplemental estrogen and caloric restriction reduce obesity-induced periprostatic white adipose inflammation in mice
Priya Bhardwaj, Takahiro Ikeda, Xi Kathy Zhou, et al.
Molecular Cancer
|
May 11, 2019
Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression
Soyoung Choi, Dunrui Wang, Xiang Chen, et al.
Leukemia
|
March 4, 2020
The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK<sup>-</sup> anaplastic large cell lymphoma by regulating the DNA helicase HELLS
Valentina Fragliasso, Akanksha Verma, Gloria Manzotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2019
Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas
Jennifer K Lue, Sathyen A Prabhu, Yuxuan Liu, et al.
Page
of 9